Why Did Relaxo Footwears Report a Decline in FY25 Profit?
Relaxo Footwears Limited, India’s largest footwear manufacturer by volume and value, reported a subdued set of numbers for the fourth quarter and full financial year ended March 31, 2025. Revenue for FY25 stood at ₹2,790 crore, marking a 4% decline from ₹2,914 crore in FY24. EBITDA came in at ₹382 crore with a margin of 13.7%, while profit after tax dropped 15% year-on-year to ₹170 crore.
In Q4 FY25, the company generated revenue of ₹695 crore, which was down 7% from ₹747 crore in the same period last year but improved 4% sequentially from Q3 FY25. EBITDA for the March quarter came in at ₹112 crore with a margin of 16.1%, flat on an annual basis but up sharply from the previous quarter. Net profit for Q4 was reported at ₹56 crore, reflecting an 8% year-on-year decline but a 70% sequential increase from Q3’s ₹33 crore.
Management characterised FY25 as a “year of consolidation,” with performance impacted by muted demand trends and strategic changes to its distribution and operational models.
What Led to Revenue and Margin Pressures in FY25?
The full-year revenue decline stemmed largely from persistent weakness in demand for mid-range footwear, a key volume contributor for Relaxo. This segment has been adversely affected by inflationary pressures in India’s semi-urban and rural markets, which together form a substantial part of the company’s customer base.
Moreover, internal restructuring aimed at modernising distribution logistics and digitising market channels caused short-term disruptions. The company overhauled its go-to-market strategy, launched the “Relaxo Parivaar” mobile platform to manage retail and distributor relationships, and pivoted to a “Brand As Seller” approach for e-commerce operations. These moves, while strategically critical, temporarily suppressed topline momentum.
On the operational front, investments in a tech-enabled warehousing system and enhancements to the supply chain added cost overheads during the year, compressing EBITDA in absolute terms, even though margins stayed relatively steady due to disciplined cost control.
How Did EBITDA Margins Hold Up Despite Revenue Headwinds?
Relaxo demonstrated margin resilience in the face of declining revenue. The FY25 EBITDA margin of 13.7% compares only slightly lower to 14.0% in FY24. In Q4 FY25, the EBITDA margin held firm at 16.1%, matching the prior year’s Q4 level and marking a 362-basis-point improvement over Q3.
This margin stability was largely due to supply chain efficiencies, tighter cost management, and a refined product mix that reduced reliance on low-margin SKUs. Sequential improvements in profitability also suggest that the operational investments made during FY25 are beginning to yield returns.
These efficiencies helped insulate Relaxo from the full impact of soft revenue performance and lay a foundation for earnings quality enhancement in FY26.
What Did Management Say About FY25 and the FY26 Growth Outlook?
Chairman and Managing Director Ramesh Kumar Dua described FY25 as a foundational year focused on repositioning the business for long-term competitiveness. According to the company’s commentary, the performance downturn was expected and linked to internal changes as well as external headwinds in consumer demand.
Dua highlighted that the bottom of the cycle may now have been reached. He expressed confidence that FY26, particularly the second half, would show the tangible benefits of the restructuring initiatives. He added that Relaxo is prioritising profitable growth, and not just topline recovery, through a combination of digital investments, sharper product curation, and enhanced operating leverage.
Among the key initiatives for FY26 are expanded product lines for online platforms, enhanced warehouse operations, a focus on direct-to-retail distribution, and improved marketing ROI.
What Does Sentiment Analysis Reveal About Relaxo Footwears Stock Post-Q4 FY25?
Relaxo Footwears’ stock performance in recent quarters mirrors its earnings narrative. Following a significant correction from its 2022 peak near ₹1,200, the stock has largely traded in the ₹850–₹880 band in May 2025. The muted reaction to Q4 results—despite a sequential jump in profit—signals restrained optimism among investors.
Technically, the stock is holding above its 200-day moving average, suggesting underlying support, but upside has been capped due to limited growth triggers. The Relative Strength Index (RSI) currently hovers in the neutral zone, indicating neither overbought nor oversold conditions.
Institutional sentiment is bifurcated. Domestic Institutional Investors (DIIs), including major mutual funds, have marginally increased holdings post Q4, reflecting confidence in the company’s long-term margin recovery and operational strategy. Conversely, Foreign Institutional Investors (FIIs) have slightly trimmed stakes, citing concerns about the consumer discretionary sector and mid-cap volatility in India.
Quarterly shareholding patterns reflect this cautious institutional posture. While DIIs appear to be positioning for a medium-term rebound, FIIs are awaiting clearer signs of topline growth and volume stabilisation before re-entering in size.
Brokerage houses remain conservative. Most have assigned a ‘Hold’ rating, with commentary indicating potential re-rating contingent on FY26 earnings visibility and volume traction. A minority of analysts have flagged a “buy-on-dips” opportunity below ₹820 for long-term investors who are bullish on domestic consumption themes.
The current buy-sell-hold breakdown suggests:
Buy: For long-term investors with a 2–3 year view betting on rural demand recovery and supply chain-driven margin gains
Hold: For existing investors seeking to avoid booking losses amid expected Q3–Q4 FY26 gains
Sell: For short-term momentum traders awaiting confirmed breakout above resistance levels near ₹900
Given Relaxo’s strong brand recall, operational integrity, and robust distribution infrastructure, investor sentiment is beginning to stabilise—though conviction remains tentative pending improved earnings traction.
What Is the Outlook for Relaxo Footwears in FY26?
FY26 is shaping up as an inflection year for Relaxo Footwears. The full-year impact of cost rationalisation, tech integration, and supply chain revamp is expected to become evident by H2FY26. While revenue growth in H1 may remain flattish, management guidance points to improved margins and operating leverage.
Sectorally, a potential rebound in rural consumption—driven by increased government spending ahead of India’s 2026 general elections—could lift demand in Relaxo’s core markets. The footwear major’s move toward higher-margin digital and urban-focused products could also support blended ASPs and mitigate volume pressures.
Competitive pressures from international brands and digital-first D2C entrants will remain a challenge. However, Relaxo’s deep-rooted retail relationships, cost-effective manufacturing, and focus on omnichannel sales are seen as durable moats.
Market analysts expect Relaxo to focus on brand-led pricing, operating leverage, and leaner working capital cycles in FY26. The company’s ability to expand its premium product footprint without diluting mass-market appeal will be pivotal to its long-term growth trajectory.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.
